🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

An International Study on Pediatric Patients With Rare Tumors.

Recruitingn/aAges 0 Years - 18 YearsAllAzienda Ospedaliera di Padova
NCT07072143 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center. * Written informed consent from the patient and/or the parent/legal guardian Exclusion Criteria: * Absence of Written informed consent from the patient and/or the parent/legal guardian
💊

What it tests

  • Not listed
📍

Where

1 site
Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova]
Padova, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy